- Korea Ginseng Corporation, the world's best-selling ginseng brand, introduced the best adaptogens, Korean Red Ginseng , that can help golfers

CERRITOS, Calif. , Sept. 19, 2022 /PRNewswire/ -- Korea Ginseng Corporation, the World's No.1 ginseng brand, introduced Korean Red Ginseng as the best adaptogens, and shared the way to take adaptogens for golfers.

Because of the lengthy pandemic, large numbers of the MZ Generation(Millennials + Gen Z) are now gravitating to the game, as is obvious from the appearance of such social media hashtags as #golfstagram. According to The R&A and Sports Marketing Surveys (SMS), the game of golf is expanding worldwide. As of December, 2021, there were 66.6 million golfers, a significant increase of 5.5 million players over the last survey, in 2016.

If anyone is into golf and want to be a better player, but feel like the energy level isn't sufficient when playing golf, taking regular adaptogens supplements can help boost the performance.[1] [2] [3]

From the adaptogens definition, An adaptogen is a plant extract that promotes general health and well-being; reduces stress, anxiety, and fatigue; and increases resistance to disease. In addition to their stress-reducing capabilities, adaptogens also have many other health benefits. Adaptogenic herbs  may help boost people's immune system, regulate hormones, control appetite, and more.

The main difference between an adaptogen and a vitamin or mineral is that an adaptogen is not only good for one area of the body but good for the whole body. This makes it a useful addition to the daily supplement routine if people are looking to improve their health.

"Adaptogens are natural supplements that increase energy levels and reduce stress," said Rian (Heungsil) Lee, the CEO of Korea Ginseng Corporation U.S. "Taking good adaptogens is a good way to help golfers become better players. This supplement helps to improve blood circulation as well as balance hormones."

Why Do Golfers Need Korean Red Ginseng as Adaptogens?

According to the King, Arnold Daniel Palmer , "Success in golf depends less on strength of body than upon strength of mind and character." Golf is a mental game, and the top golfers all have one thing in common: the superb concentration that comes with a high level of mental energy.

Korean Red Ginseng is one of the most widely used herbs, and recognized as an adaptogen. Korean Red Ginseng is a superfood that can be beneficial to the health and performance. It's not just good for people's physical strength, but it can also improve the mental focus and stamina so they can perform better during the game[1] [2] [3 ]. With the Korean Red Ginseng, Rhodiola, Ashwagandha, Rooibos, Holy Basil are also known as adaptogens.

For this reason and many others, many professional athletes have expressed their love of Korean Red Ginseng. In addition to sponsoring several of these well-known sports stars, Korea Red Ginseng Corp. actively supports a wide variety of golf tournaments and events.

How to Take Korean Red Ginseng as Adaptogens?

It's important to remember that adaptogens are not stimulants, so don't expect them to give people a boost like coffee or caffeine. They have a very low risk of side effects, but they do have a long "half-life" meaning they take time to build up in the system and reach full potency.

If interested in learning more about the health benefits of Korean Red Ginseng, talk with an associate at the local natural health store or explore the plethora of products and resources available online. People can take them in a variety of forms such as Teas, Capsules and tablets, tinctures, Powders, drinks, goomies.

Also, Korean Ginseng Corporation is presenting various Korean Red Ginseng products include KORESELECT the new line for american market, Natural Products Expo East, In Pennsylvania Convention Center, on September, booth #3905

Korea Ginseng Corporation (KGC) is the world's number one ginseng brand. Established in 1899, it is one of the most proven and trusted herbal dietary supplement manufacturers, providing the highest quality, traditionally harvested Korean Red Ginseng products to support health and well-being. KGC runs four regional headquarters in the United States , China , Japan , and Taiwan , in addition to South Korea , and exports products to over 40 countries. With over 40% world market share, its presence spans Asia , Europe , the Middle East region and the U.S. KGC's family of brands include KORESELECT, CheongKwanJang, Good Base, and Donginbi. The KGC brands, inclusive of over 250 products, use the most exceptional ginseng combined with the finest herbs and ingredients to deliver superior products to meet everyone's needs.

For more information, visit https://www.kgcus.com/.

[1] (National Library of Medicine)Effect of Korean Red Ginseng in individuals exposed to high stress levels: a 6-week, double-blind, randomized, placebo-controlled trial

[2] (ScienceDirect)Effect of Korean Red Ginseng in individuals exposed to high stress levels: a 6-week, double-blind, randomized, placebo-controlled trial

[3]https://kgcus.com/blogs/ginseng-101/adaptogens

View original content to download multimedia:https://www.prnewswire.com/news-releases/korea-ginseng-corp-introduced-korean-red-ginseng-as-good-adaptogens-for-golfers-301627697.html

SOURCE KGC (Korea Ginseng Corp.)

UBS's Colin Bristow raised his rating on the stock to Buy from Neutral, saying Well Street's expectations for sales of Mounjaro are too low.

The exclusive licensing agreement with GSK will fund Spero's (SPRO) existing operations and extend its current cash runway beyond 2024.

Less than five months after discouraging conversations with the U.S. Food and Drug Administration led Spero Therapeutics Inc. to pause work on a drug and lay off 110 people, the company is licensing that same drug to GSK plc for up to $291 million.

This drugmaker has earned two new drug approvals in as many months, but its success isn't reflected in its market valuation yet.

By David Bautz, PhD NASDAQ:VIRI READ THE FULL VIRI RESEARCH REPORT Financial Update On September 23, 2022, Virios Therapeutics, Inc. (NASDAQ:VIRI) announced the closing of a previously announced underwritten public offering of 10 million shares of common stock at a price of $0.50 per share. The company raised gross proceeds of $5.0 million before deducting underwriting discounts, commissions, and

Shares of Bristol Myers Squibb (NYSE: BMY) were bouncing 3.4% higher as of 3:31 p.m. ET on Thursday after slipping a little earlier this week. Instead, today's move appeared to be the result of investors seeking relatively safe stocks as the Nasdaq Composite index and Russell 2000 small-cap index fell. Bristol Myers Squibb has seemed to be sort of a safe haven for investors throughout much of 2022.

A respiratory virus that pops up every two years is causing an increase in pediatric hospitalizations in some parts of the country, according to the Centers for Disease Control and Prevention. The CDC said earlier this month that more children and teens tested positive for a type of enterovirus called EV-D68 in July and August of this year compared with the same two-month period in 2019, 2020 and 2021. It also said that hospitals in several U.S. regions had notified the agency in August about an increasing number of hospitalizations of pediatric patients who tested positive for rhinoviruses or enteroviruses.

Evaxion (EVAX) enrolls the first patient in the phase IIb study evaluating its cancer therapy, EVX-01 in combination with Keytruda, for treating melanoma.

Shares of Spectrum Pharmaceuticals Inc. were down 22.0% in premarket trading on Friday, the day after a Food and Drug Administration committee voted 9-4 that the benefits of the company's experimental lung-cancer drug do not outweigh the risks. The FDA is not required to follow the committee's advice when deciding when to approve a new drug but often does. The regulator is expected to make its decision on or before Nov. 24. Spectrum on Friday also announced a five-year debt financing plan with S

Roche's (RHHBY) eye drug, Vabysmo and AstraZeneca's (AZN) asthma drug Tezspire get approval in Europe. The FDA approves expanded use of Lilly's (LLY) cancer drug, Retevmo.

Khosla Ventures is throwing its weight behind a new CRISPR/Cas13 startup, and Sesen Bio, formerly Eleven Biotherapeutics, is finally shutting down after 14 years.

Eli Lilly's blockbuster potential diabetes drug Mounjaro is "de-risked and transformative," an analyst said Thursday as he updated LLY stock.

OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today announced that Dr. Philippe Genereux, Director of the Structural Heart Program at Morristown Medical Center in New Jersey, and his team, performed the first use of SavvyWire in a transcatheter aortic valve replacement (TAVR) procedure in the United States.

Around one in five vaccinated Britons with Omicron or Delta strain experienced diarrhoea as a symptom

Shares of Eli Lilly & Co. Inc. gained 2.5% in premarket trading on Thursday after UBS upgraded the stock to buy from neutral, saying Mounjaro, the company's newly approved Type 2 diabetes drug, could be "the biggest drug ever." UBS analysts predict peak sales of $25 billion if the therapy is also approved as a treatment for weight management in people with obesity. "Tirzepatide's robust efficacy in both obesity and [Type 2 diabetes] should drive sales into a range that we believe could see this

Ionis (IONS) posts data from the phase IIb SOLANO study on ION449 for treating hypercholesterolemia. Though the study met the primary endpoint, ION449 will not advance into phase III development.

Regulatory and pipeline updates from BMY and GILD are the key highlights from the biotech sector during the past week.

‘I happen to be a practising Roman Catholic. My church doesn’t even make that argument now,’ president says of abortion bans

Earlier this week Georgia Democratic gubernatorial nominee Stacey Abrams corrected a popular anti-abortion claim that a fetus has a heartbeat at six weeks of pregnancy. Abrams, who is running a campaign centered on abortion access to unseat Republican Gov. Brian Kemp spoke out against the medically incorrect term during a panel discussion in Atlanta on […]